Eupraxia Pharmaceuticals IncNASDAQ:EPRXView on Canadian Exchange
- LAST PRICE3.3700
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots3.2100/ 1
- Ask / Lots5.6600/ 1
- Open / Previous Close--- / 3.3700
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | EPRX |
|---|---|---|
| 09:32 ET | 4355 | 3.6 |
| 09:35 ET | 611 | 3.68 |
| 09:37 ET | 300 | 3.6 |
| 09:39 ET | 1500 | 3.54 |
| 09:42 ET | 100 | 3.5329 |
| 09:44 ET | 100 | 3.5329 |
| 09:48 ET | 111 | 3.6 |
| 09:51 ET | 1500 | 3.6 |
| 10:00 ET | 1200 | 3.56 |
| 10:02 ET | 100 | 3.54 |
| 10:06 ET | 150 | 3.69 |
| 10:13 ET | 621 | 3.45 |
| 10:15 ET | 628 | 3.4509 |
| 10:18 ET | 240 | 3.45 |
| 10:20 ET | 1611 | 3.5 |
| 10:22 ET | 150 | 3.4045 |
| 10:26 ET | 2770 | 3.6399 |
| 10:40 ET | 2841 | 3.36 |
| 10:47 ET | 100 | 3.361 |
| 10:49 ET | 558 | 3.36 |
| 10:51 ET | 248 | 3.28 |
| 10:54 ET | 200 | 3.37 |
| 10:58 ET | 500 | 3.27 |
| 11:09 ET | 100 | 3.3051 |
| 11:18 ET | 1650 | 3.3601 |
| 11:20 ET | 1224 | 3.3206 |
| 11:21 ET | 121 | 3.4 |
| 11:25 ET | 133 | 3.3505 |
| 11:27 ET | 400 | 3.36 |
| 11:32 ET | 221 | 3.384 |
| 11:34 ET | 2200 | 3.42 |
| 11:52 ET | 150 | 3.37 |
| 12:06 ET | 286 | 3.3307 |
| 12:15 ET | 150 | 3.36 |
| 12:28 ET | 308 | 3.42 |
| 12:33 ET | 200 | 3.46 |
| 01:31 ET | 1000 | 3.56 |
| 01:54 ET | 100 | 3.3601 |
| 02:16 ET | 158 | 3.48 |
| 02:41 ET | 500 | 3.48 |
| 03:32 ET | 287 | 3.49 |
| 03:35 ET | 200 | 3.37 |
Nov 20, 2024
DJ Eupraxia Pharma Shares Jump Following Data From Eosinophilic Esophagitis Trial, from 10:36AM ET on Wednesday Nov 20, 2024 by Dow Jones
10:36AM ET on Wednesday Nov 20, 2024 by Dow JonesEupraxia's DiffuSphere(TM) Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months, from 7:00AM ET on Wednesday Nov 20, 2024 by Dow Jones
7:00AM ET on Wednesday Nov 20, 2024 by Dow Jones
Nov 14, 2024
Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting, from 5:00PM ET on Thursday Nov 14, 2024 by Dow Jones
5:00PM ET on Thursday Nov 14, 2024 by Dow JonesDJ Eupraxia Pharmaceuticals Initiated at Buy by Rodman & Renshaw, from 7:12AM ET on Thursday Nov 14, 2024 by Dow Jones
7:12AM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 13, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Eupraxia Pharmaceuticals Inc | 168.5M | 0.0x | --- |
Company Information
Eupraxia Pharmaceuticals Inc. is a Canada-based clinical-stage biotechnology company. The Company is focused on the development of locally delivered, extended-release products. The Company’s lead product candidate, EP-104, is designed to address the significant unmet medical need and market demand for conditions where long-lasting symptom relief is essential to effective treatment. The primary targets for EP-104 have been identified as knee osteoarthritis (OA) and eosinophilic esophagitis (EoE). The product in development for OA is called EP-104IAR and the product in development in EoE is called EP-104GI. DiffuSphere, a proprietary, polymer based micro-sphere technology, is designed to facilitate targeted drug delivery, with extended duration of effect, and offers multiple, highly tunable pharmacokinetic (PK) profiles.
Contact Information
- Headquarters
- 201-2067 Cadboro Bay Rd.VICTORIA, BC, Canada V8R 5G4
- Phone
- 250-590-3968
- Fax
- 250-590-2588
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $168.5M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 35.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.42 |
EPS | $-1.38 |
Book Value | $0.11 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
